Vancouver’s Aspect Biosystems today announced a US $20 million Series A financing round led by Radical Ventures with participation from investors Pangaea Ventures, Pallasite Ventures, and Rhino Ventures. Aspect is a biotechnology company pioneering microfluidic 3D bioprinting of human tissues and will use this capital to advance multiple tissue therapeutic programs, expand its technology platform […]